美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ASTRAZENECA PLC ADRhedged

53.28

0.0000

成交量：- -

成交額：- -

市值：159.83萬

市盈率：- -

高：53.28

開：53.28

低：53.28

收：53.28

52周最高：56.90

52周最低：44.36

股本：3.00萬

流通股本：1.00萬

量比：2.68

換手率：- -

股息：0.58

股息率：1.08%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

阿斯利康的乳腺癌藥物晚期臨床試驗失敗

阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。

投洽會「金鑰匙」再啓：雙向投資動能強勁，未來產業站上C位

安進（AMGN）聯合療法III期臨床達主要終點

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/AZNH"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1789156800000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"停牌","change":0,"latestTime":"09-11 16:00:00 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":2.6812474453400963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.6812474453400963,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":44.36,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666574841","title":"阿斯利康的乳腺癌藥物晚期臨床試驗失敗","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574841","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574841?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:29","pubTimestamp":1789158581,"startTime":"0","endTime":"0","summary":"阿斯利康的乳腺癌药物晚期临床试验失败路透9月11日-阿斯利康（AstraZeneca）AZN.L周五表示，其一款乳腺癌药物在晚期临床试验中未能达到改善无进展生存期的主要目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4T4531G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","IE00B3T34201.USD","LU0289739699.SGD","LU0058720904.USD","LU2237443465.HKD","LU2468319806.SGD","LU2089984988.USD","LU2237443895.HKD","BK4588","BK4585","AZN","LU0310800379.SGD","LU0128525929.USD","LU1829250122.USD","LU2237443382.USD","LU0708994859.HKD","LU2237443978.SGD","LU2417539215.USD","LU2456880835.USD","LU2237443622.USD","LU0109394709.USD","LU2462157665.USD","LU0889565916.HKD","LU0432979614.USD","LU2237443549.SGD","LU2236285917.USD","BK4007","LU0320765992.SGD","LU1267930573.SGD","AZNH","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2322448957.HKD","IBB","MRNY","PSCH","PJP","IYH","BK4588","FTXH","IDNA","LU1992135399.USD","FBT","TMED","IEIH","LU2272731600.USD","RXL","SYNB","WDNA","LU2272731865.HKD","RSPH","IBRN","SBIO","LFSC","LU1992135472.HKD","BK4585","LU2322448791.USD","BIB","BIOY","HELX","AZNH","CANC","LU2473716301.USD","IEHS","XBIX","PPH","MEDI","XPH","IE00B5TLWC47.USD","GNOM","BBP","MRNX","BME","LU2272731782.SGD","PBPH","PBE","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533439","title":"投洽會「金鑰匙」再啓：雙向投資動能強勁，未來產業站上C位","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533439","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533439?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 20:38","pubTimestamp":1788957480,"startTime":"0","endTime":"0","summary":"9月8日至11日，第二十六届中国国际投资贸易洽谈会(以下简称“投洽会”)在厦门国际博览中心举行。本届大会以“扩大双向投资共促全球发展”为永久主题，围绕“投资中国”“中国投资”“国际投 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260909/c679754294.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260909/c679754294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU0432979614.USD","LU0708994859.HKD","LU2237443549.SGD","LU2237443895.HKD","LU0109394709.USD","BK4588","LU1267930573.SGD","LU2237443622.USD","BK4585","BK4568","LU0058720904.USD","LU0128525929.USD","LU2417539215.USD","LU0889565916.HKD","LU0320765992.SGD","LU0289739699.SGD","LU2237443382.USD","LU2089984988.USD","LU2462157665.USD","IE00B3T34201.USD","LU2468319806.SGD","LU2456880835.USD","LU2237443978.SGD","AZNH","AZN","LU0310800379.SGD","BK4007","LU2236285917.USD","LU0029864427.USD","LU2237443465.HKD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666712586","title":"安進（AMGN）聯合療法III期臨床達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2666712586","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666712586?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 16:59","pubTimestamp":1788944360,"startTime":"0","endTime":"0","summary":"金吾财经 | 安进公布，双特异性T细胞衔接器Imdelltra联合阿斯利康PD-L1抑制剂英飞凡，在广泛期小细胞肺癌的后期临床试验中实现总生存期延长。这家加州生物制药企业披露III期DeLLphi-305研究中期数据，该试验达成广泛期小细胞肺癌患者总生存期主要终点。该项全球试验评估该组合作为一线维持治疗，受试者既往接受过包含英飞凡的治疗且病情未发生进展。研究同时达成无进展生存期、客观缓解率两项次要终点。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305840","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","AZNH","LU2456880835.USD","LU2242652126.USD","IE0002141913.USD","LU0128525929.USD","BK4599","LU0109394709.USD","PJP","BK4534","BK4566","LU2237443978.SGD","PBE","AMGN","LU1571399168.USD","LU0122379950.USD","LU1829250122.USD","LU2237443382.USD","SG9999001440.SGD","IBB","LU2468319806.SGD","LU0029864427.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU2462157665.USD","AZN","BIB","BK4533","BK4585","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU0889565916.HKD","BK4568","LU0708994859.HKD","LU1023059063.AUD","LU2112291526.USD","TBXU","LU2236285917.USD","LU2237443895.HKD","IBBQ","LU2237443622.USD","BK4139","LU0289739699.SGD","LU1267930573.SGD","BK4581","LU2242646821.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":41,"pageCount":1,"totalSize":162,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AZNH\",params:#limit:6,delay:false,,,undefined,":[]}}